I think there's a strong/massive opportunity for Bisantrene to be used in combination with the with the PD-1 inhibitors (due to treatment resistance) - Bisantrene could stop the treatment resistance of PD-1 inhibitors.
The kind of thing that will get big pharma very, very interested.
1420 studies for Keytruda
https://clinicaltrials.gov/ct2/resu...uda&cntry=&state=&city=&dist=
1286 studies for OPDIVO
https://clinicaltrials.gov/ct2/resu...IVO&cntry=&state=&city=&dist=
732 studies for YERVOY
https://clinicaltrials.gov/ct2/resu...VOY&cntry=&state=&city=&dist=
![]()
![]()
(colour-highlighted group above highlighted below - massive market - noting cancer resistance to PD-1 inhibitors)
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
- Forums
- ASX - By Stock
- RAC
- Ann: Race AGM presentations and strategic update
Ann: Race AGM presentations and strategic update, page-29
-
- There are more pages in this discussion • 156 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.68 |
Change
0.020(1.20%) |
Mkt cap ! $286.2M |
Open | High | Low | Value | Volume |
$1.68 | $1.68 | $1.61 | $177.8K | 108.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | $1.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 4999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1100 | 1.640 |
1 | 31221 | 1.625 |
1 | 5000 | 1.620 |
1 | 30000 | 1.615 |
2 | 16249 | 1.610 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 4999 | 1 |
1.720 | 17729 | 2 |
1.730 | 25792 | 1 |
1.750 | 508 | 1 |
1.780 | 4483 | 1 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |